My Local Study
MARCH 12, 2025
Learn about the power of inclusive data and the transformative impact of women’s participation in our blog. For much of medical history, women were notably absent from clinical trials. This absence created a significant gap in our understanding of how medical treatments affect women, leading to potentially harmful consequences. It wasn’t until 1993, with the.
Rethinking Clinical Trials
MARCH 12, 2025
Sean Mann In this Friday’s PCT Grand Rounds, Sean Mann of RAND will present “Spillover Due to Constraints on Care Delivery: A Potential Source of Bias in Pragmatic Clinical Trials.” The Grand Rounds session will be held on Friday, March 14, 2025, at 1:00 pm eastern. Mann is a senior policy analyst at RAND. Join the online meeting. The post March 12, 2025: In This Week’s PCT Grand Rounds, Spillover as a Potential Source of Bias in Pragmatic Trials appeared first on Rethink
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MARCH 12, 2025
Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy by Ionis to treat polycythemia vera (PV).
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 12, 2025
(Laura Leyshon/Getty Images) If you head to the shops to buy bread, you’ll face a variety of different options. But it can be hard to work out the difference between all the types on sale. For instance, you might have a vague idea that wholemeal or wholegrain bread is healthy. But what’s the difference?
Advertisement
There’s been a rapid shift towards decentralization in clinical trials & it’s clear why. The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. Tele visits, digital consent, new monitoring sensors, & direct-to-patient supply are virtual tools that existed before the pandemic, but now there’s swift adoption of these methods because they’ve been proven to help launch & complete trials more effectively.
Bio Pharma Dive
MARCH 12, 2025
Funded by investors such as Flagship and General Catalyst, the AI startup claims its platform will help scientists speed up the experimentation process.
Pharmaceutical Technology
MARCH 12, 2025
The two companies will work together on Zealands amylin analogue petrelintide as a monotherapy and in combination therapies.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
ACRP blog
MARCH 12, 2025
The benefits of diversity and inclusion in clinical research are widely recognized, yet the financial and operational costs of these efforts are often overlooked. Practical strategies are needed to identify and mitigate these hidden costs, helping organizations create effective and sustainable strategies. These will be more important than ever if current U.S.
Bio Pharma Dive
MARCH 12, 2025
The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs it acquired from Carmot.
Pharmaceutical Technology
MARCH 12, 2025
Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care offerings in the US.
Bio Pharma Dive
MARCH 12, 2025
Ionis’ drug, sapablursen, is currently being tested in a Phase 2 trial in patients with polycythemia vera.
Advertiser: FourKites
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.
Pharmaceutical Technology
MARCH 12, 2025
Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the governments of Canada and Alberta for an R&D facility.
Drug Patent Watch
MARCH 12, 2025
The Unseen Heroes of Generic Drugs: Stability Testing 101 As a consumer, have you ever stopped to think about the rigorous process that goes into bringing a generic version of your favorite medication to market? It's not just a matter of copying a formula and slapping a new label on it. Behind the scenes, generic drug manufacturers are working tirelessly to ensure that their products are safe, effective, and identical to their branded counterparts.
Pharmaceutical Technology
MARCH 12, 2025
WuXi XDC Cayman has signed a memorandum of understanding (MoU) with South Korea-based AbTis to advance next-generation ADCs.
XTalks
MARCH 12, 2025
Following the success of Issue 3 , which focused on the critical importance of patient diversity in clinical research, Xtalks is thrilled to announce Xtalks Clinical Edge Issue 4. This 4th edition will explore the exciting space of next-gen clinical research, unpacking novel technologies, strategies and trends that are gradually steering how the industry moves forward.
Speaker: Steve Goldstein, Sales Leader
Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? What are some of the top challenges your customers face and how do you approach understanding what’s most important to them? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., to discover critical strategies and approaches you can take to engage your customers, achieve g
Pharmaceutical Technology
MARCH 12, 2025
The specialist in temperature-sensitive pharmaceutical shipments, is introducing the industrys most comprehensive cold chain portfolio.
Pharma Times
MARCH 12, 2025
Phase 2a TREE study assesses safety and efficacy of leriglitazone
pharmaphorum
MARCH 12, 2025
Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma.
Pharmaceutical Commerce
MARCH 12, 2025
The partnership focuses on enhancing the patient experience by providing greater affordability and access to specialty meds.
pharmaphorum
MARCH 12, 2025
Psyon is running a pilot study of a game that aims to raise awareness of HPV infection and vaccination in sub-Saharan Africa.
Pharmaceutical Commerce
MARCH 12, 2025
The latest news for pharma industry insiders.
pharmaphorum
MARCH 12, 2025
MSD has opened the doors of a $1bn facility at its site in Durham, North Carolina, that will be used to produce its HPV vaccine Gardasil.
Pharmaceutical Commerce
MARCH 12, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, comments on the primary factors causing manufacturing bottlenecks in the space, along with how the industry can overcome them in order to scale up production.
pharmaphorum
MARCH 12, 2025
The EU has proposed legislation to safeguard the supply of critical medicines but pharma and patient groups are concerned about the details
CTTI (Clinical Trials Transformation Initiative)
MARCH 12, 2025
Presentation: Turning Trust into Action Date: Monday, April 7, 4:00 – 4:30 p.m. Presenter: Sabrena Mervin-Blake (CTTI) The post IncluDE Site Solutions Summit appeared first on CTTI.
pharmaphorum
MARCH 12, 2025
Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad
Pharmaceutical Technology
MARCH 12, 2025
Europes drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.
pharmaphorum
MARCH 12, 2025
Watch an engaging interview with Tony Lee and Ed Ahn as they discuss JP Morgan Week 2025 and share their insights on the future of finance and investments.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 12, 2025
The Central government may soon look into amending the Drugs Rules, 1945 to add provisions related to loan licensees applying for manufacturing of a drug for examination, test or analysis of biologics, vaccines and antibiotics among others, to bring in better clarity.
pharmaphorum
MARCH 12, 2025
Learn how Biostats and medical writing can polish your data, AI, and Clinical Study Reports (CSR) to make it shine. Explore the impact of this important process.
Pharma Times
MARCH 12, 2025
Company seeks new direction after negative CHMP opinion on KIZFIZO
pharmaphorum
MARCH 12, 2025
On 11th February, pharmaphorum was invited by Curia to attend a parliamentary roundtable focussed on womens health, held at the House of Commons and hosted in collaboration with Members of Parliament and leading healthcare experts.
FDA Law Blog
MARCH 12, 2025
The American Conference Institutes 21st Annual Paragraph IV Disputes is scheduled to take place from April 29-30, 2025 at The Altman Building in New York, NY. Widely recognized as the industry gold standard, the conference unites leaders from brand-name and generic drug companies, alongside federal judges, the U.S. PTOs PTAB, the FTC, and the FDA, to tackle the critical legal, regulatory, and business issues shaping pharmaceutical patent litigation.
XTalks
MARCH 12, 2025
In this episode, Vera spoke with Ann Belin, PhD, founder and CEO of Rejuvenate Biomed , a biotech company leveraging AI-driven platforms to develop therapies for age-related diseases and promote healthy aging. Rejuvenate Biomed is aiming to transform the treatment landscape for diseases such as sarcopenia, neuromuscular, metabolic and neurodegenerative disorders.
Intouch Solutions
MARCH 12, 2025
At EVERSANA INTOUCH, we believe in the power of GROW TALENT, a cultural belief that we live and breathe every day. Last week, our agency learning & development team, along with account and PMO leaders, hosted the grand finale of this years Business Excellence Program in Chicago. This cohort-based training is designed to enhance communication, presentation, strategic thinking, and business management skills.
Expert insights. Personalized for you.
51 
Let's personalize your content